Joan K. Bardsley, MBA, RN, CDE, discusses the theme of this year's annual meeting of the Association of Diabetes Educators.
Accuracy of glucose monitoring devices and protection of data are important issues for patients with diabetes.
Clinicians should consider a number of factors when weighing the risks and benefits of using SGLT2 inhibitors in patients with diabetes.
Clinicians may be able to help ease the problem of female sexual dysfunction by talking to patients and learning about new treatments.
Diabetes educators can help patients with obesity achieve long-term weight loss and prevent gaining it back.
The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.
The Holy Grail of health care is delivery of quality care at a reduced cost. But what exactly is quality care? How do we really know we are cutting costs?
Data show that nonnutritive sweeteners likely do not change appetite or cause diabetes and may actually help with weight loss.
Joan K. Bardsley, MBA, RN, CDE, FAADE, offers her perspective on the current state of health care and what needs to change.
Taking steps to increase the visibility and convenience of healthier foods may help people lose weight.
Clinicians must be aware of the overlap between nonalcoholic fatty liver disease and nonalcoholic steatohepatitis and other metabolic disorders.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Bariatric Surgery: An Effective Treatment for Type 2 Diabetes
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation